reduce basal insulin when starting glp-1 receptor agonist Adjusting Your Pump a Medication Advances in GLP-1 receptor agonists

Insurers in the U.S

doi: 10.3390/medicina55060233

This trend aligns with broader increases in GLP-1 RA utilization across the general population during the same period ( 15 )

GLP-1RAs ameliorate ROS-induced or hyperglycemia-induced apoptosis through modulating IL-6 production and ER stress-induced by hyperhomocysteinemia, via stromal cell-derived factor (SDF)-1/C-X-C motif receptor 7 (CXCR7) -AMPK/p38-MAPK axis [113-115]

For example, liraglutide, a GLP-1 analog, is resistant to the action of dipeptidyl peptidase IV (DPP IV)

This has raised questions about potential conflicts of interest and highlights the importance of independent research